Restore Desire. Reignite Intimacy. Reclaim Your Sexual Vitality.

PT-141 — also known as Bremelanotide and marketed under the FDA-approved brand name Vyleesi — is a synthetic melanocortin peptide originally derived from Melanotan II. 

It is the first and only centrally acting peptide approved by the FDA for the treatment of Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women.

What makes PT-141 fundamentally different from every other sexual health treatment on the market is where it acts in the body.
Unlike Viagra or Cialis — which act peripherally by increasing blood flow to the genitals — PT-141 works directly in the brain, activating melanocortin receptors (MC3R and MC4R) in the hypothalamus — the region responsible for regulating sexual desire, motivation, and arousal.
This is not a mechanical fix. It is a neurological one.

At Forever Young BHRT, we also offer PT-141 as a physician-supervised off-label therapy for men experiencing low libido or erectile dysfunction — particularly in cases where PDE5 inhibitors have failed or are contraindicated.

PT-141 follows a precise neurological signaling pathway that makes it unlike any other sexual health therapy available today.

Step 1 — Melanocortin Receptor Activation
Following subcutaneous injection, PT-141 binds to melanocortin receptors (MC3R and MC4R) in the hypothalamus — the brain's master regulator of sexual motivation and arousal.

Step 2 — Dopamine Pathway Stimulation
Receptor activation triggers increased dopaminergic activity in the brain's reward and motivation centers — the same pathways that govern desire, pleasure, and emotional drive.

Step 3 — Oxytocin Release
PT-141 promotes the release of oxytocin — the bonding and intimacy hormone — deepening the emotional dimension of sexual response alongside the physical.

Step 4 — Natural Sexual Arousal & Desire
Within 45–60 minutes of injection, patients experience a genuine, neurologically driven increase in sexual desire and arousal — not forced, not mechanical, but a real activation of the brain's own desire circuitry.

Because PT-141 works through the brain's natural signaling architecture — rather than overriding peripheral vascular mechanisms — it can be effective in patients where traditional treatments have failed, and it produces results that feel organic rather than pharmaceutical.

The most important distinction between PT-141 and traditional erectile dysfunction medications is where they act in the body.

Viagra and Cialis (PDE5 inhibitors) work peripherally — they inhibit the enzyme phosphodiesterase type 5, causing smooth muscle relaxation and increased blood flow to the genitals. They do not address desire, motivation, or the neurological components of sexual dysfunction. For patients whose primary issue is low libido, emotional disconnection, or arousal disorder — not vascular blood flow — PDE5 inhibitors offer minimal benefit.

PT-141 works centrally — in the brain — activating the melanocortin system to generate genuine neurological desire and arousal. For patients who have tried Viagra or Cialis without success, or whose sexual dysfunction has a psychological, neurological, or hormonal root cause, PT-141 represents a fundamentally different and often far more effective therapeutic pathway.

Hypoactive Sexual Desire Disorder (HSDD) is the most common form of female sexual dysfunction — characterized by persistently low sexual desire that causes personal distress. It is estimated to affect 10–12% of premenopausal women in the United States and is significantly underdiagnosed and undertreated.

Contributing factors include:

    Hormonal shifts during perimenopause and menopause
    Antidepressant use (SSRIs and SNRIs commonly suppress libido)
    Postpartum hormonal changes
    Chronic stress and elevated cortisol
    Neurological changes in the brain's desire signaling pathways

PT-141 (Vyleesi) received FDA approval in June 2019 for HSDD in premenopausal women based on two robust Phase III clinical trials — the RECONNECT studies — involving over 1,200 women. Results demonstrated statistically significant improvements in sexual desire, arousal, and distress reduction compared to placebo.

At Forever Young BHRT, PT-141 therapy for women is integrated into our comprehensive women's hormone health program — often alongside bioidentical estrogen, progesterone, and testosterone optimization for a full-spectrum approach to sexual wellness and overall vitality.

While PT-141's FDA approval is specific to HSDD in premenopausal women, it has been extensively studied and widely used clinically in men for:

    Erectile dysfunction — particularly in patients who have not responded to PDE5 inhibitors
    Low libido and reduced sexual motivation
    Sexual dysfunction with a psychological or neurological component
    Performance anxiety-related dysfunction where the vascular mechanism is intact but desire and arousal are impaired

Because PT-141 works through a completely different mechanism than Viagra or Cialis, it can be effective in men for whom those medications have failed or produced undesirable side effects.

At Forever Young BHRT, men's PT-141 therapy is prescribed as part of a comprehensive clinical evaluation that includes testosterone optimization, full hormone panel review, and complete health history — ensuring the most appropriate and personalized protocol for each patient.

30–45 minutes post-injection	Onset of warmth, mild flushing, beginning of increased desire

45–90 minutes	Heightened sexual desire, enhanced arousal, peak neurological activation

1–4 hours	Full peak effects — sustained desire, arousal, and sexual responsiveness

4–12 hours	Gradual natural return to baseline — residual benefits may persist
With consistent use	Some patients report cumulative improvements in baseline libido over time

 PT-141 is administered via a subcutaneous injection — a simple, quick self-injection into the abdomen using a slim insulin-style syringe — approximately 45 minutes before anticipated sexual activity.

At Forever Young BHRT, we provide:

    A comprehensive consultation and health evaluation before prescribing
    Complete in-office training on proper injection technique
    Detailed take-home dosing and administration instructions
    Ongoing physician monitoring and protocol adjustments as needed

Standard PT-141 Dosing Protocol:

    Dose: 1.0–1.75 mg subcutaneously
    Timing: 45–60 minutes before anticipated sexual activity
    Frequency: As needed — maximum 8 doses per month
    Storage: Refrigerated — stable for up to 30 days after reconstitution

At Forever Young BHRT, sexual health is treated with the same clinical rigor, personalization, and compassion as every other dimension of your wellness. We understand that low libido and sexual dysfunction profoundly affect quality of life, relationships, and self-confidence — and we approach these concerns without judgment and with genuine medical expertise.

When you come to us for PT-141 therapy, you receive:
🔬 Comprehensive laboratory evaluation including full hormone panels before treatment begins 

👨‍⚕️ Physician-supervised prescribing from experienced hormone and peptide specialists 

💉 Personalized dosing tailored to your biology, health history, and goals 

🔗 Integration with broader hormone optimization protocols when appropriate 

🏥 A private, discreet, and welcoming clinic environment in Oakland Park, FL 

📋 Ongoing monitoring and follow-up to ensure optimal outcomes

Sexual vitality is not a luxury — it is an essential component of overall health and wellbeing. We're here to help you reclaim it.